Campuses:

Type 2 diabetes

Wednesday, November 7, 2018 - 4:30pm - 5:00pm
Yuanjia Wang (Columbia University)
Current guidelines for treatment decision making largely rely on data from ran- domized controlled trials (RCTs) studying average treatment effects. They may be inadequate to make individualized treatment decisions in real-world settings. Large- scale electronic health records (EHR) provide opportunities to fulfill the goals of personalized medicine and learn individualized treatment rules (ITRs) depending on patient-specific characteristics from real-world patient data.
Subscribe to RSS - Type 2 diabetes